Johnson Matthey Recalls Remifentanil HCl API Due to Impurity Issues
Johnson Matthey Inc. is recalling Remifentanil HCl active pharmaceutical ingredient (API) because an unknown impurity exceeded specification limits.
- Product
- Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.
- Category
- Drug
- Distribution
- Distributed nationwide